secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001493152-25-023779
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Fertility Q3 revenue up 23% to $1.76M; net loss widens to $2.6M
--------------------------------------------------------------------

- Revenue $1,757,094 (+23% YoY); clinic revenue $1,722,223 (+21% YoY).
- Net loss $(2.6)M vs $(1.6)M; Adjusted EBITDA $(947,568) vs $(945,949).
- INVOcell device revenue grew 130% YoY on training support and pricing.
- Company expects to complete at least one acquisition in coming months.
- Federal policy change in Oct 2025 allows standalone infertility benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315225023779/0001493152-25-023779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315225023779/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-023779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer